FDC Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 8, 2025, 8:00 pm

Market Cap	6,543 Cr.
Current Price	402
High / Low	659/364
Stock P/E	23.8
Book Value	141
Dividend Yield	1.24 %
ROCE	18.4 %
ROE	14.2 %
Face Value	1.00
PEG Ratio	-20.76

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for FDC Ltd

Competitors of FDC Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
MPS Pharmaa Ltd	6.71 Cr.	3.51	4.33/3.05		0.80	0.00 %	9.15 %	34.9 %	10.0
Gujarat Themis Biosyn Ltd	2,663 Cr.	244	390/192	50.6	20.5	0.27 %	45.0 %	33.8 %	1.00
Gujarat Terce Laboratories Ltd	53.1 Cr.	71.5	94.9/32.1	18.0	11.9	0.00 %	9.72 %	3.44 %	10.0
Gujarat Inject (Kerala) Ltd	38.0 Cr.	26.0	29.0/8.74	38.8	6.64	0.00 %	2.65 %	2.08 %	10.0
Godavari Drugs Ltd	70.4 Cr.	93.5	155/79.0	11.4	55.4	0.00 %	14.4 %	15.5 %	10.0
Industry Average	17,255.37 Cr	1,081.84		42.42	185.80	0.37%	16.00%	16.32%	6.27

All Competitor Stocks of FDC Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	342	341	495	445	409	435	536	486	458	462	638	514	464
Expenses	294	322	417	378	360	386	414	410	374	406	492	444	417
Operating Profit	48	19	78	67	49	49	122	76	84	56	147	70	47
OPM %	14%	6%	16%	15%	12%	11%	23%	16%	18%	12%	23%	14%	10%
Other Income	13	10	19	13	18	7	29	27	25	20	28	35	19
Interest	1	1	1	1	1	1	1	1	1	1	1	1	1
Depreciation	9	9	9	10	10	10	10	10	10	10	11	14	13
Profit before tax	51	19	87	69	57	45	141	93	98	65	163	90	51
Tax %	30%	45%	19%	25%	28%	32%	22%	25%	19%	29%	27%	20%	28%
Net Profit	36	10	71	52	41	31	110	70	79	46	119	72	37
EPS in Rs	2.11	0.62	4.26	3.12	2.46	1.85	6.62	4.29	4.87	2.84	7.31	4.42	2.28

Last Updated: February 28, 2025, 8:05 pm

Below is a detailed analysis of the quarterly data for FDC Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹464.00 Cr.. The value appears to be declining and may need further review. It has decreased from 514.00 Cr. (Sep 2024) to ₹464.00 Cr., marking a decrease of 50.00 Cr..
For Expenses, as of Dec 2024, the value is ₹417.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 444.00 Cr. (Sep 2024) to ₹417.00 Cr., marking a decrease of 27.00 Cr..
For Operating Profit, as of Dec 2024, the value is ₹47.00 Cr.. The value appears to be declining and may need further review. It has decreased from 70.00 Cr. (Sep 2024) to ₹47.00 Cr., marking a decrease of 23.00 Cr..
For OPM %, as of Dec 2024, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 14.00% (Sep 2024) to 10.00%, marking a decrease of 4.00%.
For Other Income, as of Dec 2024, the value is ₹19.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Sep 2024) to ₹19.00 Cr., marking a decrease of 16.00 Cr..
For Interest, as of Dec 2024, the value is ₹1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 1.00 Cr..
For Depreciation, as of Dec 2024, the value is ₹13.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 14.00 Cr. (Sep 2024) to ₹13.00 Cr., marking a decrease of 1.00 Cr..
For Profit before tax, as of Dec 2024, the value is ₹51.00 Cr.. The value appears to be declining and may need further review. It has decreased from 90.00 Cr. (Sep 2024) to ₹51.00 Cr., marking a decrease of 39.00 Cr..
For Tax %, as of Dec 2024, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from 20.00% (Sep 2024) to 28.00%, marking an increase of 8.00%.
For Net Profit, as of Dec 2024, the value is ₹37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 72.00 Cr. (Sep 2024) to ₹37.00 Cr., marking a decrease of 35.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 2.28. The value appears to be declining and may need further review. It has decreased from ₹4.42 (Sep 2024) to 2.28, marking a decrease of ₹2.14.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 4:21 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	772	845	888	994	1,013	1,074	1,089	1,341	1,331	1,525	1,784	1,943	2,078
Expenses	591	638	690	765	769	841	860	1,038	997	1,271	1,533	1,604	1,759
Operating Profit	181	207	199	229	243	233	229	304	334	254	251	339	320
OPM %	23%	24%	22%	23%	24%	22%	21%	23%	25%	17%	14%	17%	15%
Other Income	46	39	46	39	44	45	42	57	95	76	50	102	102
Interest	2	3	2	1	1	1	1	3	3	3	4	4	4
Depreciation	28	25	39	34	35	35	33	37	38	37	39	40	49
Profit before tax	198	218	204	232	252	241	237	320	388	289	258	396	369
Tax %	22%	38%	27%	27%	25%	28%	28%	25%	22%	25%	25%	23%
Net Profit	155	135	148	169	189	174	170	240	301	216	194	305	274
EPS in Rs	8.49	7.61	8.33	9.48	10.60	9.95	9.74	14.03	17.85	12.82	11.70	18.75	16.85
Dividend Payout %	26%	30%	27%	24%	21%	0%	0%	6%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-12.90%	9.63%	14.19%	11.83%	-7.94%	-2.30%	41.18%	25.42%	-28.24%	-10.19%	57.22%
Change in YoY Net Profit Growth (%)	0.00%	22.53%	4.56%	-2.35%	-19.77%	5.64%	43.48%	-15.76%	-53.66%	18.05%	67.40%

FDC Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	9%
5 Years:	12%
3 Years:	13%
TTM:	8%

Compounded Profit Growth
10 Years:	9%
5 Years:	11%
3 Years:	1%
TTM:	-5%

Stock Price CAGR
10 Years:	10%
5 Years:	12%
3 Years:	13%
1 Year:	-9%

Return on Equity
10 Years:	14%
5 Years:	13%
3 Years:	12%
Last Year:	14%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 12:33 am

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	18	18	18	18	18	18	18	17	17	17	17	16	16
Reserves	766	827	919	1,065	1,252	1,259	1,428	1,530	1,717	1,940	1,965	2,081	2,275
Borrowings	3	3	2	1	1	1	1	15	15	32	28	21	20
Other Liabilities	179	211	210	182	197	228	194	250	207	281	333	350	376
Total Liabilities	966	1,059	1,148	1,266	1,468	1,505	1,640	1,813	1,956	2,270	2,343	2,468	2,688
Fixed Assets	289	284	393	675	678	674	682	674	689	705	699	680	805
CWIP	7	18	29	20	6	13	12	24	19	105	198	261	143
Investments	416	417	489	325	491	471	585	665	790	886	806	843	1,066
Other Assets	254	340	237	246	293	348	360	451	458	575	640	684	674
Total Assets	966	1,059	1,148	1,266	1,468	1,505	1,640	1,813	1,956	2,270	2,343	2,468	2,688

Below is a detailed analysis of the balance sheet data for FDC Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹16.00 Cr..
For Reserves, as of Sep 2024, the value is ₹2,275.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹2,081.00 Cr. (Mar 2024) to ₹2,275.00 Cr., marking an increase of 194.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹20.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from ₹21.00 Cr. (Mar 2024) to ₹20.00 Cr., marking a decrease of 1.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹376.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹350.00 Cr. (Mar 2024) to ₹376.00 Cr., marking an increase of 26.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹2,688.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹2,468.00 Cr. (Mar 2024) to ₹2,688.00 Cr., marking an increase of 220.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹805.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹680.00 Cr. (Mar 2024) to ₹805.00 Cr., marking an increase of 125.00 Cr..
For CWIP, as of Sep 2024, the value is ₹143.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹261.00 Cr. (Mar 2024) to ₹143.00 Cr., marking a decrease of 118.00 Cr..
For Investments, as of Sep 2024, the value is ₹1,066.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹843.00 Cr. (Mar 2024) to ₹1,066.00 Cr., marking an increase of 223.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹674.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹684.00 Cr. (Mar 2024) to ₹674.00 Cr., marking a decrease of 10.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹2,688.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹2,468.00 Cr. (Mar 2024) to ₹2,688.00 Cr., marking an increase of 220.00 Cr..

Notably, the Reserves (₹2,275.00 Cr.) exceed the Borrowings (20.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	150	150	128	174	154	150	112	250	207	162	155	221
Cash from Investing Activity +	-107	-55	-89	-73	-144	21	-121	-98	-77	-145	11	-17
Cash from Financing Activity +	-63	-75	-48	-97	0	-169	-0	-142	-129	-10	-180	-202
Net Cash Flow	-20	19	-9	4	11	1	-8	10	1	7	-14	2

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	178.00	204.00	197.00	228.00	242.00	232.00	228.00	289.00	319.00	222.00	223.00	318.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	20	26	25	23	27	28	29	34	30	20	25	22
Inventory Days	117	116	132	134	148	166	184	180	189	210	183	216
Days Payable	72	90	94	84	81	101	82	101	68	94	99	103
Cash Conversion Cycle	66	51	64	72	94	93	131	113	152	135	109	135
Working Capital Days	24	2	11	21	23	29	45	41	50	47	49	139
ROCE %	23%	25%	21%	22%	21%	19%	17%	21%	22%	15%	13%	19%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	69.36%	69.50%	69.49%	69.49%	69.49%	69.49%	69.66%	69.66%	69.66%	69.66%	69.66%	69.66%
FIIs	4.52%	4.34%	3.99%	3.77%	3.80%	2.06%	2.42%	2.43%	2.65%	2.51%	2.62%	2.67%
DIIs	5.86%	6.07%	6.77%	7.76%	8.27%	9.13%	8.12%	7.76%	6.94%	6.72%	6.02%	6.08%
Public	20.27%	20.09%	19.75%	18.98%	18.44%	19.32%	19.80%	20.15%	20.76%	21.11%	21.71%	21.60%
No. of Shareholders	86,503	65,318	63,172	59,871	57,012	56,717	56,928	55,341	52,377	50,634	55,400	55,228

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Nippon India Small Cap Fund	4,257,262	0.41	154.24	30,083	2025-03-10	14051.72%
ICICI Prudential Smallcap Fund	1,509,088	0.91	54.67	30,083	2025-03-10	4916.41%
ICICI Prudential Multi Asset Fund	704,002	0.1	25.51	30,083	2025-03-10	2240.2%
Bandhan Emerging Businesses Fund	525,874	0.85	19.05	30,083	2025-03-10	1648.08%
ICICI Prudential Multicap Fund	467,004	0.19	16.92	30,083	2025-03-10	1452.39%
Samco Active Momentum Fund	429,098	3.61	15.55	30,083	2025-03-10	1326.38%
ITI Pharma and Healthcare Fund	69,869	1.97	2.53	30,083	2025-03-10	132.25%
Nippon India Nifty Smallcap 250 Index Fund	30,083	0.15	1.09	30,083	2025-03-10	0%
Motilal Oswal Nifty Smallcap 250 Index Fund	18,887	0.15	0.68	30,083	2025-03-10	-37.22%
SBI Nifty Smallcap 250 Index Fund	13,865	0.15	0.5	30,083	2025-03-10	-53.91%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	1.00	1.00	1.00	1.00	1.00
Basic EPS (Rs.)	18.58	11.66	12.81	17.72	13.94
Diluted EPS (Rs.)	18.58	11.66	12.81	17.72	13.94
Cash EPS (Rs.)	21.19	14.03	15.01	20.08	16.28
Book Value[Excl.RevalReserv]/Share (Rs.)	128.81	119.43	115.89	102.72	90.51
Book Value[Incl.RevalReserv]/Share (Rs.)	128.81	119.43	115.89	102.72	90.51
Revenue From Operations / Share (Rs.)	119.34	107.51	90.51	78.98	78.62
PBDIT / Share (Rs.)	27.04	18.13	19.54	25.54	21.16
PBIT / Share (Rs.)	24.58	15.79	17.33	23.30	18.97
PBT / Share (Rs.)	24.34	15.54	17.14	22.97	18.77
Net Profit / Share (Rs.)	18.74	11.68	12.81	17.84	14.09
NP After MI And SOA / Share (Rs.)	18.75	11.70	12.82	17.85	14.03
PBDIT Margin (%)	22.65	16.86	21.58	32.33	26.91
PBIT Margin (%)	20.60	14.68	19.14	29.49	24.13
PBT Margin (%)	20.39	14.45	18.94	29.08	23.87
Net Profit Margin (%)	15.70	10.86	14.14	22.59	17.92
NP After MI And SOA Margin (%)	15.70	10.87	14.16	22.60	17.84
Return on Networth / Equity (%)	14.55	9.78	11.05	17.37	15.50
Return on Capital Employeed (%)	18.55	12.89	14.63	22.44	20.70
Return On Assets (%)	12.36	8.28	9.53	15.40	13.23
Asset Turnover Ratio (%)	0.80	0.77	0.72	0.70	0.77
Current Ratio (X)	3.43	3.30	3.67	4.58	3.76
Quick Ratio (X)	2.18	2.24	2.56	3.52	2.91
Inventory Turnover Ratio (X)	1.63	1.85	1.75	1.64	1.77
Dividend Payout Ratio (NP) (%)	0.00	0.00	0.00	0.00	5.71
Dividend Payout Ratio (CP) (%)	0.00	0.00	0.00	0.00	4.94
Earning Retention Ratio (%)	0.00	0.00	0.00	0.00	94.29
Cash Earning Retention Ratio (%)	0.00	0.00	0.00	0.00	95.06
Interest Coverage Ratio (X)	109.11	73.60	106.74	125.53	105.92
Interest Coverage Ratio (Post Tax) (X)	76.62	48.42	70.97	89.32	71.51
Enterprise Value (Cr.)	6886.08	4231.47	4298.40	4791.75	3318.24
EV / Net Operating Revenue (X)	3.54	2.37	2.81	3.59	2.47
EV / EBITDA (X)	15.64	14.07	13.03	11.12	9.17
MarketCap / Net Operating Revenue (X)	3.56	2.39	2.84	3.62	2.49
Retention Ratios (%)	0.00	0.00	0.00	0.00	94.28
Price / BV (X)	3.30	2.15	2.22	2.78	2.17
Price / Net Operating Revenue (X)	3.56	2.39	2.84	3.62	2.49
EarningsYield	0.04	0.04	0.04	0.06	0.07

After reviewing the key financial ratios for FDC Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
For Basic EPS (Rs.), as of Mar 24, the value is 18.58. This value is within the healthy range. It has increased from 11.66 (Mar 23) to 18.58, marking an increase of 6.92.
For Diluted EPS (Rs.), as of Mar 24, the value is 18.58. This value is within the healthy range. It has increased from 11.66 (Mar 23) to 18.58, marking an increase of 6.92.
For Cash EPS (Rs.), as of Mar 24, the value is 21.19. This value is within the healthy range. It has increased from 14.03 (Mar 23) to 21.19, marking an increase of 7.16.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 128.81. It has increased from 119.43 (Mar 23) to 128.81, marking an increase of 9.38.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 128.81. It has increased from 119.43 (Mar 23) to 128.81, marking an increase of 9.38.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 119.34. It has increased from 107.51 (Mar 23) to 119.34, marking an increase of 11.83.
For PBDIT / Share (Rs.), as of Mar 24, the value is 27.04. This value is within the healthy range. It has increased from 18.13 (Mar 23) to 27.04, marking an increase of 8.91.
For PBIT / Share (Rs.), as of Mar 24, the value is 24.58. This value is within the healthy range. It has increased from 15.79 (Mar 23) to 24.58, marking an increase of 8.79.
For PBT / Share (Rs.), as of Mar 24, the value is 24.34. This value is within the healthy range. It has increased from 15.54 (Mar 23) to 24.34, marking an increase of 8.80.
For Net Profit / Share (Rs.), as of Mar 24, the value is 18.74. This value is within the healthy range. It has increased from 11.68 (Mar 23) to 18.74, marking an increase of 7.06.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 18.75. This value is within the healthy range. It has increased from 11.70 (Mar 23) to 18.75, marking an increase of 7.05.
For PBDIT Margin (%), as of Mar 24, the value is 22.65. This value is within the healthy range. It has increased from 16.86 (Mar 23) to 22.65, marking an increase of 5.79.
For PBIT Margin (%), as of Mar 24, the value is 20.60. This value exceeds the healthy maximum of 20. It has increased from 14.68 (Mar 23) to 20.60, marking an increase of 5.92.
For PBT Margin (%), as of Mar 24, the value is 20.39. This value is within the healthy range. It has increased from 14.45 (Mar 23) to 20.39, marking an increase of 5.94.
For Net Profit Margin (%), as of Mar 24, the value is 15.70. This value exceeds the healthy maximum of 10. It has increased from 10.86 (Mar 23) to 15.70, marking an increase of 4.84.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 15.70. This value is within the healthy range. It has increased from 10.87 (Mar 23) to 15.70, marking an increase of 4.83.
For Return on Networth / Equity (%), as of Mar 24, the value is 14.55. This value is below the healthy minimum of 15. It has increased from 9.78 (Mar 23) to 14.55, marking an increase of 4.77.
For Return on Capital Employeed (%), as of Mar 24, the value is 18.55. This value is within the healthy range. It has increased from 12.89 (Mar 23) to 18.55, marking an increase of 5.66.
For Return On Assets (%), as of Mar 24, the value is 12.36. This value is within the healthy range. It has increased from 8.28 (Mar 23) to 12.36, marking an increase of 4.08.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.80. It has increased from 0.77 (Mar 23) to 0.80, marking an increase of 0.03.
For Current Ratio (X), as of Mar 24, the value is 3.43. This value exceeds the healthy maximum of 3. It has increased from 3.30 (Mar 23) to 3.43, marking an increase of 0.13.
For Quick Ratio (X), as of Mar 24, the value is 2.18. This value exceeds the healthy maximum of 2. It has decreased from 2.24 (Mar 23) to 2.18, marking a decrease of 0.06.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.63. This value is below the healthy minimum of 4. It has decreased from 1.85 (Mar 23) to 1.63, marking a decrease of 0.22.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Interest Coverage Ratio (X), as of Mar 24, the value is 109.11. This value is within the healthy range. It has increased from 73.60 (Mar 23) to 109.11, marking an increase of 35.51.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 76.62. This value is within the healthy range. It has increased from 48.42 (Mar 23) to 76.62, marking an increase of 28.20.
For Enterprise Value (Cr.), as of Mar 24, the value is 6,886.08. It has increased from 4,231.47 (Mar 23) to 6,886.08, marking an increase of 2,654.61.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 3.54. This value exceeds the healthy maximum of 3. It has increased from 2.37 (Mar 23) to 3.54, marking an increase of 1.17.
For EV / EBITDA (X), as of Mar 24, the value is 15.64. This value exceeds the healthy maximum of 15. It has increased from 14.07 (Mar 23) to 15.64, marking an increase of 1.57.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 3.56. This value exceeds the healthy maximum of 3. It has increased from 2.39 (Mar 23) to 3.56, marking an increase of 1.17.
For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Price / BV (X), as of Mar 24, the value is 3.30. This value exceeds the healthy maximum of 3. It has increased from 2.15 (Mar 23) to 3.30, marking an increase of 1.15.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 3.56. This value exceeds the healthy maximum of 3. It has increased from 2.39 (Mar 23) to 3.56, marking an increase of 1.17.
For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of FDC Ltd as of March 12, 2025 is: ₹385.95

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, FDC Ltd is Overvalued by 3.99% compared to the current share price 402.00

Intrinsic Value of FDC Ltd as of March 12, 2025 is: 381.53

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, FDC Ltd is Overvalued by 5.09% compared to the current share price 402.00

Last 5 Year EPS CAGR: -1.15%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 19.83%, which is a positive sign. The company has higher reserves (1,463.38 cr) compared to borrowings (11.00 cr), indicating strong financial stability. The company has shown consistent growth in sales (269.92 cr) and profit (277.08 cr) over the years.	The stock has a high average Working Capital Days of 40.08, which may not be favorable. The stock has a high average Cash Conversion Cycle of 101.25, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in FDC Ltd:
1. Net Profit Margin: 15.7%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 18.55% (Industry Average ROCE: 16%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 14.55% (Industry Average ROE: 16.32%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 76.62
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 2.18
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 23.8 (Industry average Stock P/E: 42.42)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

FDC Ltd. is a Public Limited Listed company incorporated on 23/09/1940 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1940PLC003176 and registration number is 003176. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1916.19 Cr. and Equity Capital is Rs. 16.28 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	B-8, MIDC Industrial Estate, Chhatrapati Sambhaji Nagar Aurangabad District Maharashtra 431136	investors@fdcindia.com www.fdcindia.com

Management
Name	Position Held
CA. Uday Kumar Gurkar	Chairman & Ind.Director
Mr. Mohan A Chandavarkar	Managing Director
Mr. Nandan M Chandavarkar	Joint Managing Director
Mr. Ameya A Chandavarkar	Executive Director & CEO
Mr. Ashok A Chandavarkar	Executive Director
Ms. Nomita R Chandavarkar	Non Exe.Non Ind.Director
CA. Swati S Mayekar	Independent Director
Dr. Mahesh Bijlani	Independent Director
Mr. Vijay Maniar	Independent Director
Mr. Vijay Nautamlal Bhatt	Independent Director

FAQ

What is the latest intrinsic value of FDC Ltd?

The latest intrinsic value of FDC Ltd as on 10 March 2025 is ₹385.95, which is 3.99% lower than the current market price of 402.00, indicating the stock is overvalued by 3.99%. The intrinsic value of FDC Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹6,543 Cr. and recorded a high/low of ₹659/364 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹2,275 Cr and total liabilities of ₹2,688 Cr.

What is the Market Cap of FDC Ltd?

The Market Cap of FDC Ltd is 6,543 Cr..

What is the current Stock Price of FDC Ltd as on 10 March 2025?

The current stock price of FDC Ltd as on 10 March 2025 is ₹402.

What is the High / Low of FDC Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of FDC Ltd stocks is ₹659/364.

What is the Stock P/E of FDC Ltd?

The Stock P/E of FDC Ltd is 23.8.

What is the Book Value of FDC Ltd?

The Book Value of FDC Ltd is 141.

What is the Dividend Yield of FDC Ltd?

The Dividend Yield of FDC Ltd is 1.24 %.

What is the ROCE of FDC Ltd?

The ROCE of FDC Ltd is 18.4 %.

What is the ROE of FDC Ltd?

The ROE of FDC Ltd is 14.2 %.

What is the Face Value of FDC Ltd?

The Face Value of FDC Ltd is 1.00.